Kraig Biocraft Laboratories Inc (KBLB)

[GTman1]

After the forward split in 2009, Kim knew he would eventually need to revert to a more typical share structure some day.  Our share structure right now isn't normal for a biotech our size.  If we organically waited until our share price was at $2, then our market cap would be $1.7 billion.  A company shouldn't have to wait until it's worth $1.7 billion to be able to just "barely" make it onto the NASDAQ, which is what most here are asking for.
 
There are plenty of biotechs already on the NASDAQ that are smaller companies than Kraig Labs with no products and no revenues.  They are doing R&D and hoping for their own breakthroughs too.  In fact, currently there are 2702 individual companies listed on the NASDAQ.  About 36% of them are worth less than Kraig Labs current market cap, and about 75% of them are worth less than the $1.7 Billion market cap some here think the company needs to be at before uplisting through NASDAQs "minimum" requirement of $2/share.

A reverse split would give us a more typical share structure for a biotech our size where outstanding shares are closer to 100 million, as apposed to 1 billion.

Also, just a side note: Kim can uplist at $2 a share.  And no, it doesn't have to be for 90 days.  But even for those who believe we need to organically get to $4 first before we uplist, ask yourself this: Do we really need to be worth $3.4 billion to be uplisted to the NASDAQ?  That's bigger than 86% of their listed companies